Analystreport

Correvio Pharma Corp (NASDAQ: CORV) was downgraded by analysts at Mackie to a "hold" rating. They now have a $1.60 price target on the stock.

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report